[The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy].
D002994:Clofibrate / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000378:metabolism*; D007294:Inositol / Q000627:therapeutic use*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D009539:Nicotinic Acids / Q000627:therapeutic use*
D004338:Drug Combinations; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D009539:Nicotinic Acids; D007294:Inositol; D002994:Clofibrate
Zur Frage des Typenwandels bei Hyperlipoproteinaemie (Typ IIb, IV, V) unter der Therapie mit Clofibrat und m-Inositolnicotinat.